US 11845747
Ester and carbonate pyrimidine compounds as JAK kinase inhibitors
granted A61KA61K45/06A61K9/0014
Quick answer
US patent 11845747 (Ester and carbonate pyrimidine compounds as JAK kinase inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K45/06, A61K9/0014, A61K9/06, A61P